He WM, Zhang XY, Xie WG, Lv DP, Shen QD. Expression level of myocardial enzymes in patients with schizophrenia: Predictive value in the occurrence of violence. World J Psychiatry 2024; 14(9): 1346-1353 [PMID: 39319237 DOI: 10.5498/wjp.v14.i9.1346]
Corresponding Author of This Article
Qun-Di Shen, MBBS, Associate Chief Technician, Department of General Affairs, Shaoxing Seventh People's Hospital, No. 1234 Shengli West Road, Yuecheng District, Shaoxing 312000, Zhejiang Province, China. shenqundi@163.com
Research Domain of This Article
Psychiatry
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Wei-Min He, Department of Rehabilitation Ward, Shaoxing Seventh People's Hospital, Shaoxing 312000, Zhejiang Province, China
Xin-Yuan Zhang, Dan-Ping Lv, Department of Laboratory, Shaoxing Seventh People's Hospital, Shaoxing 312000, Zhejiang Province, China
Wei-Gen Xie, Department of Medical, Shaoxing Seventh People's Hospital, Shaoxing 312000, Zhejiang Province, China
Qun-Di Shen, Department of General Affairs, Shaoxing Seventh People's Hospital, Shaoxing 312000, Zhejiang Province, China
Author contributions: Shen QD was the guarantor and designed the study; He WM and Zhang XY participated in the acquisition, analysis, interpretation of the data, and drafted the initial manuscript; Lv DP and Xie WG revised the article critically for important intellectual content; all authors contributed to the article and approved the submitted version.
Supported byThe Shaoxing Science and Technology Plan Project Plan, No. 2022A14002.
Institutional review board statement: The study was reviewed and approved by the Shaoxing No.7 Hospital Medical Ethics Committee.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Qun-Di Shen, MBBS, Associate Chief Technician, Department of General Affairs, Shaoxing Seventh People's Hospital, No. 1234 Shengli West Road, Yuecheng District, Shaoxing 312000, Zhejiang Province, China. shenqundi@163.com
Received: July 15, 2024 Revised: August 13, 2024 Accepted: August 27, 2024 Published online: September 19, 2024 Processing time: 57 Days and 18.9 Hours
Core Tip
Core Tip: This study analyzes the expression levels of myocardial enzymes in patients with schizophrenia and explores their predictive value for violent behavior. The study involved 288 cases. The study was reviewed and approved by the Shaoxing Seventh Hospital Medical Ethics Committee. Patients with schizophrenia and 100 healthy controls, and patients were divided into violent and non-violent groups based on Modified Overt Aggression Scale scores. The results showed that there was a significant difference in serum myocardial enzyme levels between patients with schizophrenia and healthy individuals, and the myocardial enzyme levels in the violent group were higher than those in the non-violent group. Previous aggressive behavior and myocardial enzyme levels are of great value for diagnosis and prognosis analysis. By monitoring these indicators, we can have a more comprehensive understanding of the patient's condition and treatment progress, providing important references for clinical management.
